Bulletin 2011/10 - European Patent Office
10.02.2013 • Views
Share Embed Flag

Bulletin 2011/10 - European Patent Office

Bulletin 2011/10 - European Patent Office

Bulletin 2011/10 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) II.1(1)<br />

• Taste masking system for non-plasticizing<br />

drugs<br />

• Système de masquage de goût pour<br />

médicaments non plastifiés<br />

(73) CIMA LABS INC., <strong>10</strong>000 Valley View Road,<br />

Eden Prairie, MN 55344-9361, US<br />

(72) Habbib, Walid, Cincinnati Ohio, 45244, US<br />

Moe, Derek, Maple Grove MN 55311, US<br />

(74) Maiwald <strong>Patent</strong>anwalts GmbH, Elisenhof<br />

Elisenstrasse 3, 80335 München, DE<br />

(62) 06717339.3 / 1 830 814<br />

A61K 31/133 → (51) A23L 1/30<br />

A61K 31/164 → (51) A23L 1/30<br />

A61K 31/19 → (51) A61P 17/00<br />

A61K 31/195 → (51) A61P 17/00<br />

(51) A61K 31/35 (11) 1 088 098 B1<br />

A61K 31/426 A61K 31/4523<br />

A61K 31/47 A61P 31/18<br />

(25) En (26) En<br />

(21) 99931861.1 (22) 23.06.1999<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE<br />

(43) 04.04.2001<br />

(86) US 1999/014119 23.06.1999<br />

(87) WO 1999/067417 1999/52 29.12.1999<br />

(30) 23.06.1998 US 90393 P<br />

(54) • ARZNEIMITTEL ZUR BEHANDLUNG VON<br />

HIV-INFIZIERTEN SÄUGETIEREN<br />

• MEDICAMENT FOR TREATING HIV-<br />

INFECTED MAMMALS<br />

• MEDICAMENT POUR LE TRAITEMENT DES<br />

MAMMIFERES AFFECTES PAR LE VIH<br />

(73) THE UNITED STATES OF AMERICA, represented<br />

by THE SECRETARY, DEPARTMENT<br />

OF HEALTH AND HUMAN SERVICES,<br />

National Institutes of Health, <strong>Office</strong> of<br />

Technology Transfer, Suite 325, 6011<br />

Executive Boulevard, Rockville, MD 20852,<br />

US<br />

THE BOARD OF TRUSTEES OF THE UNI-<br />

VERSITY OF ILLINOIS, 352 Henry Administration<br />

Building, 506 South Wright Street,<br />

Urbana, IL 61801, US<br />

(72) ERICKSON, John, W., Frederick, MD 21703,<br />

US<br />

GULNIK, Sergei, V., Frederick, MD 21702,<br />

US<br />

MITSUYA, Hiroaki, Chevy Chase, MD 20815,<br />

US<br />

GOSH, Arun K., River Forest, IL60305, US<br />

(74) Becker Kurig Straus, <strong>Patent</strong>anwälte Bavariastrasse<br />

7, 80336 München, DE<br />

(60) <strong>10</strong>179052.5<br />

(51) A61K 31/353 (11) 1 824 475 B1<br />

C07D 311/80 A61P 1/08<br />

A61P 3/00 A61P 29/00<br />

(25) En (26) En<br />

(21) 05807597.9 (22) 18.11.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

AL BA HR MK YU<br />

(43) 29.08.2007<br />

(86) EP 2005/012378 18.11.2005<br />

(87) WO 2006/053766 2006/21 26.05.2006<br />

(30) 22.11.2004 US 630556 P<br />

(54) • VERFAHREN ZUR REINIGUNG VON<br />

TRANS-(-)-DELTA9-TETRAHYDROCANNA-<br />

BINOL UND TRANS-(+)-DELTA9-TETRA-<br />

HYDROCANNABINOL<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

• METHODS FOR PURIFYING TRANS-<br />

(-)-DELTA9-TETRAHYDROCANNABINOL<br />

AND TRANS-(+)-DELTA9-TETRAHYDRO-<br />

CANNABINOL<br />

• PROCEDES DE PURIFICATION DE TRANS-<br />

(-)-DELTA9-TETRAHYDROCANNABINOL<br />

ET TRANS-(+)-DELTA9-TETRAHYDRO-<br />

CANNABINOL<br />

(73) EURO-CELTIQUE S.A., 2, avenue Charles de<br />

Gaulle, 1653 Luxembourg, LU<br />

(72) GUTMAN, Arie, L., 34996 Haifa, IL<br />

NISNEVICH, Gennady, A., 34464 Haifa, IL<br />

RUKHMAN, Igor, P.O. Box 9586, Yokneam,<br />

IL<br />

TISHIN, Boris, 33855 Haifa, IL<br />

ETINGER, Marina, 36822 Nesher, IL<br />

FEDOTEV, Irina, 35708 Haifa, IL<br />

PERTSIKOV, Boris, 36781 Nesher, IL<br />

KHANOLKAR, Ram, Coventry, RI 02816, US<br />

(74) Ehlich, Eva Susanne, Maiwald <strong>Patent</strong>anwalts<br />

GmbH Elisenhof Elisenstraße 3, 80335<br />

München, DE<br />

(60) <strong>10</strong>179360.2 / 2 289 509<br />

<strong>10</strong>179374.3<br />

(51) A61K 31/381 (11) 1 971 332 B1<br />

A61P 11/06<br />

(25) En (26) En<br />

(21) 06830792.5 (22) 22.12.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

BA HR RS<br />

(43) 24.09.2008<br />

(86) EP 2006/070135 22.12.2006<br />

(87) WO 2007/077162 2007/28 12.07.2007<br />

(30) 04.01.2006 EP 06<strong>10</strong>0055<br />

(54) • VERWENDUNG VON TIOTROPIUM-SAL-<br />

ZEN BEI DER BEHANDLUNG VON MÄSS-<br />

IGEM PERSISTIERENDEM ASTHMA<br />

• USE OF TIOTROPIUM SALTS IN THE<br />

TREATMENT OF MODERATE PERSISTENT<br />

ASTHMA<br />

• UTILISATION DES SELS DE TIOTROPIUM<br />

DANS LE TRAITEMENT DE L'ASTHME<br />

MODÉRÉ PERSISTANT<br />

(73) Boehringer Ingelheim International GmbH,<br />

Binger Straße 173, 55216 Ingelheim am<br />

Rhein, DE<br />

(84) AT BE BG CH CY CZ DK EE ES FI FR GB GR<br />

HU IE IS IT LI LT LU LV MC NL PL PT RO SE<br />

SI SK TR<br />

(73) Boehringer Ingelheim Pharma GmbH & Co.<br />

KG, Binger Strasse 173, 55216 Ingelheim am<br />

Rhein, DE<br />

(84) DE<br />

(72) ENGEL, Michael, 89077 Ulm, DE<br />

HEINRICHS, Stefan, 60389 Frankfurt, DE<br />

(74) Hammann, Heinz, et al, Boehringer Ingelheim<br />

GmbH CD-<strong>Patent</strong>s Binger Straße 173, 55216<br />

Ingelheim am Rhein, DE<br />

A61K 31/395 → (51) A61K 9/20<br />

A61K 31/40 → (51) A61K 9/16<br />

A61K 31/40 → (51) C07D 409/12<br />

(51) A61K 31/403 (11) 1 917 013 B1<br />

(25) En (26) En<br />

(21) 06777058.6 (22) 21.08.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

HR<br />

(43) 07.05.2008<br />

(86) EP 2006/008314 21.08.2006<br />

(87) WO 2007/022980 2007/09 01.03.2007<br />

537<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>10</strong>/<strong>2011</strong>) 09.03.<strong>2011</strong><br />

(30) 22.08.2005 GB 0517193<br />

(54) • VERWENDUNG VON AZABICYCLOHEXAN-<br />

DERIVATEN<br />

• USE OF AZABICYCLO HEXANE DERIVA-<br />

TIVES<br />

• UTILISATION DE DERIVES AZABICYCLO<br />

(73) GLAXO GROUP LIMITED, Glaxo Wellcome<br />

House, Berkeley Avenue, Greenford, Middlesex<br />

UB6 0NN, GB<br />

(72) HAMPRECHT, Dieter, I-37135 Verona, IT<br />

HEIDBREDER, Christian, I-37135 Verona, IT<br />

MELOTTO, Sergio, I-37135 Verona, IT<br />

MICHELI, Fabrizio, I-37135 Verona, IT<br />

YAMADA, Tadataka, Philadelphia, Pennsylvania<br />

19<strong>10</strong>2-1225, US<br />

(74) Dolton, Peter Irving Ernest, et al, GlaxoSmithKline<br />

Corporate Intellectual Property<br />

(CN9.25.1) 980 Great West Road, Brentford,<br />

Middlesex TW8 9GS, GB<br />

A61K 31/404 → (51) C07D 209/42<br />

A61K 31/404 → (51) C07D 401/06<br />

A61K 31/404 → (51) C07D 417/04<br />

A61K 31/405 → (51) C07D 209/30<br />

A61K 31/41 → (51) C07D 409/12<br />

A61K 31/415 → (51) C07D 409/04<br />

A61K 31/4155 → (51) C07D 409/04<br />

A61K 31/4178 → (51) C07D 209/30<br />

A61K 31/4184 → (51) C07D 401/14<br />

A61K 31/4184 → (51) C07D 471/04<br />

A61K 31/4188 → (51) C07D 471/04<br />

A61K 31/4192 → (51) C07D 249/06<br />

A61K 31/4196 → (51) C07D 209/30<br />

A61K 31/42 → (51) C07D 413/12<br />

A61K 31/422 → (51) C07D 413/12<br />

A61K 31/423 → (51) C07D 417/04<br />

A61K 31/425 → (51) C07D 417/04<br />

(51) A61K 31/426 (11) 1 559 427 B1<br />

A61P 13/<strong>10</strong> A61P 13/00<br />

C07D 277/40<br />

(25) Ja (26) En<br />

(21) 03770134.9 (22) 04.11.2003<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(43) 03.08.2005<br />

(86) JP 2003/014065 04.11.2003<br />

(87) WO 2004/041276 2004/21 21.05.2004<br />

(30) 07.11.2002 JP 2002323792<br />

(54) • MITTEL ZUR BEHANDLUNG VON BLA-<br />

SENHYPERAKTIVITÄT MIT EINEM ESSIG-<br />

SÄUREANILID-DERIVAT ALS WIRKSTOFF<br />

• REMEDY FOR OVERACTIVE BLADDER<br />

COMPRISING ACETIC ACID ANILIDE<br />

DERIVATIVE AS THE ACTIVE INGREDIENT<br />

• REMEDE POUR VESSIE HYPERACTIVE<br />

COMPRENANT UN DERIVE ANILIDE DE<br />

L'ACIDE ACETIQUE EN TANT QU'INGRE-<br />

DIENT ACTIF<br />

(73) Astellas Pharma Inc., 3-11, Nihonbashi-<br />

Honcho 2-chome, Chuo-ku, Tokyo, JP

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!